CFDE Data Portal | Search FAM169BP

	Label	Description
	FAM169BP Gene (Entity type)	ENSG00000293555 - protein FAM169B
	GSE216043 cisplatin 11 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE208350 H-7 Huh-7 JHH-7 4 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	KFGENEBIN:FAM169B-variant-count CUI gene has variants FAM169BP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE183535 MYC inhibition HeLa 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	LRRK1 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	RPS6KL1 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	STK33 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GTEx Nerve 20-29 vs 60-69 Down Gene Set (Entity type)	A Gene Set from GTEx

FAM169BP

ENSG00000293555 - protein FAM169B

GSE216043 cisplatin 11 v 2 human dn

A Gene Set from LINCS

GSE216043 cisplatin 11 v 1 human dn

A Gene Set from LINCS

GSE208350 H-7 Huh-7 JHH-7 4 v 3 human dn

A Gene Set from LINCS

KFGENEBIN:FAM169B-variant-count CUI gene has variants FAM169BP

A Knowledge Graph Assertion from Kids First

GSE183535 MYC inhibition HeLa 3 v 2 human dn

A Gene Set from LINCS

LRRK1 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

RPS6KL1 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

STK33 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

GTEx Nerve 20-29 vs 60-69 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.